TMRW Robotic Process Automation Platform Goes Live at San Diego Fertility Center, Vios Fertility Institute - Chicago and Reproductive Medicine Associates of New York
TMRW, creator of the first Robotic Process Automation (RPA) platform designed for in vitro fertilization, announced the commencement of a multi-site study to test its platform in a live clinical environment. The study, launched in partnership with RMA of New York, will test the platform in real time - measuring improvements achieved through automation and allowing for instant iteration of platform technology. “Advances in technology have helped countless patients build their families. Genetic testing and freezing of embryos is now routine, and success rates are higher than ever. Innovations in automation, cryostorage and monitoring will be essential to meet the needs of our current and future patients,” said Dr. Alan Copperman.
Read Press Release here.